Table 4.
Univariate and multivariate analysis of risk factors associated with adenocarcinoma and dysplasia.
| Adenocarcinoma | ||||||||
|---|---|---|---|---|---|---|---|---|
| Univariate | Multivariate | |||||||
| B | P-value | Exp(B) | 95% CI | B | P-value | Exp(B) | 95% CI | |
| Age | 0.039 | .009 | 1.040 | 0.023 | .160 | 1.023 | ||
| Gender | 0.220 | .621 | 1.246 | |||||
| Gallstones | −1.434 | .003 | 0.238 | 0.09–0.61 | −1.168 | .036 | 0.311 | 0.10–0.91 |
| Acute cholecystitis | −15.502 | .998 | 0.000 | |||||
| Low-grade dysplasia | −15.512 | .997 | 0.000 | |||||
| High-grade dysplasia | 6.191 | .000 | 488.162 | 120.58–1976.20 | 5.733 | .000 | 308.980 | 63.49–1984.71 |
| Chronic cholecystitis | −2.368 | .000 | 0.094 | 0.04–0.22 | −1.677 | .001 | 0.187 | 0.05–0.45 |
| Polyps | 2.520 | .001 | 12.434 | 2.83–54.53 | 2.940 | .000 | 18.923 | 4.12–92.51 |
| Intestinal metaplasia | 4.370 | .000 | 79.036 | 8.47–737.07 | 3.887 | .005 | 48.767 | 4.74–831.10 |
| Pyloric Metaplasia | −15.566 | .993 | 0.000 | |||||
| Constant | .00 | 0.01 | ||||||
| Dysplasia | ||||||||
|---|---|---|---|---|---|---|---|---|
| Univariate | Multivariate | |||||||
| B | P-value | Exp(B) | 95% CI | B | P-value | Exp(B) | 95% CI | |
| 0.020 | .001 | 1.021 | 1.09–1.03 | 0.023 | .000 | 1.023 | 1.01–1.03 | |
| Age | 0.064 | .730 | 1.066 | 0.65–1.35 | ||||
| Gender | −0.103 | .919 | 0.902 | 0.12–6.56 | ||||
| Polyps | 2.923 | .000 | 18.601 | 12.94–26.72 | 2.936 | .000 | 18.848 | 13.06–27.19 |
| Intestinal metaplasia | 0.514 | .065 | 1.671 | 0.96–288 | 0.205 | .490 | 1.227 | 0.68–2.19 |
| Pyloric metaplasia | −17.325 | .997 | 0.000 | 0.00–0.00 | −17.325 | .997 | 0.000 | |
| Acute cholecystitis | −0.124 | .627 | 0.883 | 0.53–1.45 | ||||
| Chronic cholecystitis | −0.088 | .618 | 0.915 | 0.64–1.29 | ||||
| Gallstones | ||||||||
| Constant | .00 | 0.04 | ||||||
The bold values indicate statistical significance at P < .05.